Members of Congress have re-authorized a federal provision prohibiting the Justice Department from interfering in state-authorized medical cannabis programs. The provision, known as the Rohrabacher-Farr amendment, was included in short-term spending legislation, House Resolution 2028, and will expire on April 28, 2017. NORML is encouraging you to tell the incoming Congress that these pivotal patient protections must remain included in any future federal spending bills.
Regulated markets for adults have not made it easier for younger people to get marijuana. U.S. News
The latest Monitoring the Future survey is out.
Actual use of the drug dropped among 8th grade students and stagnated among 12th graders. Reported annual use continued a five-year slide among 10th grade students, though the year-to-year change […]